BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37615680)

  • 21. Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkin's lymphoma.
    Zhong H; Chen J; Cheng S; Chen S; Shen R; Shi Q; Xu P; Huang H; Zhang M; Wang L; Wu D; Zhao W
    EBioMedicine; 2019 Mar; 41():167-174. PubMed ID: 30827933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic nomogram for diffuse large B-cell lymphoma incorporating the International Prognostic Index with interim-positron emission tomography findings.
    Chow A; Phillips M; Siew T; Cull G; Augustson B; Ward M; Joske D
    Intern Med J; 2013 Aug; 43(8):932-9. PubMed ID: 23692386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a radiomic-clinical nomogram for prediction of survival in patients with diffuse large B-cell lymphoma treated with chimeric antigen receptor T cells.
    Zhou Y; Zhang B; Han J; Dai N; Jia T; Huang H; Deng S; Sang S
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11549-11560. PubMed ID: 37395846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
    Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
    World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and Validation of a Novel Prognostic Nomogram for CD5-Positive Diffuse Large B-Cell Lymphoma: A Retrospective Multicenter Study in China.
    Shen Z; Wang L; Zhang B; Li T; Li D; He C; Xue Y; Wang Y; Li B; Liu Q; Zhang H; Gu W; Wang F; Wang C; Shi Y; Ye J; Zhu T; Miao Y; Huang S; Sang W
    Front Oncol; 2021; 11():754180. PubMed ID: 34804942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A nomogram based on peripheral lymphocyte for predicting 8-year survival in patients with prostate cancer: a single-center study using LASSO-cox regression.
    Chen J; Yu F; He G; Hao W; Hu W
    BMC Cancer; 2024 Feb; 24(1):254. PubMed ID: 38395827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel Prognostic Model for Patients with Primary Gastric Diffuse Large B-Cell Lymphoma.
    Lu G; Lin Z; Ruan Y; Huang H; Lin J; Pan J
    J Oncol; 2022; 2022():9636790. PubMed ID: 36339648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptome profiling reveals an integrated mRNA-lncRNA signature with predictive value for long-term survival in diffuse large B-cell lymphoma.
    Gao Q; Li Z; Meng L; Ma J; Xi Y; Wang T
    Aging (Albany NY); 2020 Nov; 12(22):23275-23295. PubMed ID: 33221755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nomogram model predicting the overall survival for patients with primary gastric mucosa-associated lymphoid tissue lymphoma.
    Wang D; Shi XL; Xu W; Shi RH
    World J Gastrointest Oncol; 2023 Mar; 15(3):533-545. PubMed ID: 37009322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Nomogram predicting the overall survival of patients with pancreatic cancer treated with radiotherapy: a study based on the SEER database and a Chinese cohort.
    Dong X; Wang K; Yang H; Cheng R; Li Y; Hou Y; Chang J; Yuan L
    Front Endocrinol (Lausanne); 2023; 14():1266318. PubMed ID: 37955009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nomogram-Based Prediction of Overall and Cancer-Specific Survival in Patients with Primary Bone Diffuse Large B-Cell Lymphoma: A Population-Based Study.
    Yang XY; He X; Zhao Y
    Evid Based Complement Alternat Med; 2022; 2022():1566441. PubMed ID: 35571733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of the International prognostic index with β2-microglobulin, platelet count and red blood cell distribution width: a new prognostic model for diffuse large B-cell lymphoma in the rituximab era.
    Chen H; Zhong Q; Zhou Y; Qin Y; Yang J; Liu P; He X; Zhou S; Zhang C; Gui L; Yang S; Zhou L; Shi Y
    BMC Cancer; 2022 May; 22(1):583. PubMed ID: 35624433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgery shows survival benefit in patients with primary intestinal diffuse large B-cell lymphoma: A population-based study.
    Wang M; Ma S; Shi W; Zhang Y; Luo S; Hu Y
    Cancer Med; 2021 May; 10(10):3474-3485. PubMed ID: 33931950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of nomograms for predicting overall survival and cancer specific survival in locally advanced breast cancer patients: A SEER population-based study.
    Yin F; Wang S; Hou C; Zhang Y; Yang Z; Wang X
    Front Public Health; 2022; 10():969030. PubMed ID: 36203704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Novel Inflammatory-Nutritional Prognostic Scoring System for Patients with Diffuse Large B Cell Lymphoma.
    Wang Z; Bao Y; Xu Z; Sun Y; Yan X; Sheng L; Ouyang G
    J Inflamm Res; 2024; 17():1-13. PubMed ID: 38193043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy.
    Zhou D; Liu X; Wang X; Yan F; Wang P; Yan H; Jiang Y; Yang Z
    BMC Cancer; 2021 Mar; 21(1):246. PubMed ID: 33685417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment and validation of systematic prognostic nomograms in patients over 60 years of age with osteosarcoma: A multicenter external verification study.
    Shao Z; Li J; Liu Z; Bi S
    Cancer Med; 2023 Apr; 12(8):9589-9603. PubMed ID: 36992547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction significance of autophagy-related genes in survival probability and drug resistance in diffuse large B-cell lymphoma.
    Xiong D; Wei X; Huang W; Zheng J; Feng R
    Aging (Albany NY); 2024 Jan; 16(2):1049-1076. PubMed ID: 38240686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prognostic nomogram constructed for relapsed or refractory diffuse large B-cell lymphoma patients.
    Jiang S; Qin Y; Liu P; Yang J; Yang S; He X; Zhou S; Gui L; Zhang C; Zhou L; Sun Y; Shi Y
    Asia Pac J Clin Oncol; 2022 Apr; 18(2):e11-e16. PubMed ID: 31264371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.